Ind-Swift to market Roche's heart disease test in India
This article was originally published in Scrip
Executive Summary
Shares of the Indian generics firm, Ind-Swift, moved up on Indian bourses after it announced plans to market Roche Diagnostics' TROP T rapid assay, a test to detect heart attacks, on the Indian market.